Latest Articles

Publication Date
Long-term adverse multi-system health outcomes of gestational diabetes mellitus: an analysis of real-world cohort data.

There is emerging evidence that gestational diabetes mellitus (GDM) increases the risk of multi-system long-term complications such as cancer and autoimmune disease, however this evidence is scarce and conflicting. Therefore, …

Published: Feb. 21, 2026, midnight
Dietary Fiber in Endometriosis: Mechanisms, Evidence, and Potential Clinical Benefits-Up-to-Date Review.

Background: Endometriosis is a chronic, estrogen-dependent inflammatory disorder. It is associated with hormonal dysregulation, pelvic pain, and a reduced quality of life. Dietary factors may influence disease development and symptom …

Published: Feb. 21, 2026, midnight
Oskari Heikinheimo explains link of endometriosis and higher risks of miscarriage, ectopic pregnancy - Contemporary OB/GYN

Oskari Heikinheimo explains link of endometriosis and higher risks of miscarriage, ectopic pregnancy Contemporary OB/GYN

Published: Feb. 19, 2026, 8:20 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal

Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally

Published: Feb. 18, 2026, noon
This surgery could slash the risk of the deadliest female cancer by almost 80% - SMH.com.au

This surgery could slash the risk of the deadliest female cancer by almost 80% SMH.com.au

Published: Feb. 18, 2026, 8 a.m.
Risk factors and prediction models for pain after endometriosis-related surgery-what do we (not) know yet.

Published: Feb. 18, 2026, midnight
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues

Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues

Published: Feb. 17, 2026, 3:15 p.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine

Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine

Published: Feb. 17, 2026, 12:15 a.m.
The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.

Letrozole and other aromatase inhibitors are increasingly recognized as first-line ovulation induction (OI) medications, offering an efficient and physiologic approach to ovarian stimulation that enhances outcomes in reproductive medicine. By …

Published: Feb. 17, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!